Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Page 1
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial.
Lancet. 2023 Jul 15;402(10397):185-195. doi: 10.1016/S0140-6736(23)00922-4. Epub 2023 Jun 5.
Lancet. 2023.
PMID: 37290461
Clinical Trial.
Semaglutide and the future of obesity care in the UK.
Fallows E, Ells L, Anand V.
Fallows E, et al.
Lancet. 2023 Jun 24;401(10394):2093-2096. doi: 10.1016/S0140-6736(23)01083-8. Epub 2023 Jun 5.
Lancet. 2023.
PMID: 37290459
No abstract available.
Item in Clipboard
WASH and health: from global estimates to whys and hows.
Heller L, Carneiro M.
Heller L, et al.
Lancet. 2023 Jun 17;401(10393):2017-2018. doi: 10.1016/S0140-6736(23)00765-1. Epub 2023 Jun 5.
Lancet. 2023.
PMID: 37290462
No abstract available.
Item in Clipboard
Sequencing checkpoint inhibitor therapy in renal cell carcinoma.
Beckermann KE, Rini BI.
Beckermann KE, et al.
Lancet. 2023 Jul 15;402(10397):160-161. doi: 10.1016/S0140-6736(23)01058-9. Epub 2023 Jun 5.
Lancet. 2023.
PMID: 37290460
No abstract available.
Item in Clipboard
Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes.
Wolf J, Johnston RB, Ambelu A, Arnold BF, Bain R, Brauer M, Brown J, Caruso BA, Clasen T, Colford JM Jr, Mills JE, Evans B, Freeman MC, Gordon B, Kang G, Lanata CF, Medlicott KO, Prüss-Ustün A, Troeger C, Boisson S, Cumming O.
Wolf J, et al.
Lancet. 2023 Jun 17;401(10393):2060-2071. doi: 10.1016/S0140-6736(23)00458-0. Epub 2023 Jun 5.
Lancet. 2023.
PMID: 37290458
Free PMC article.
Item in Clipboard
Cite
Cite